openPR Logo
Press release

LATAM Adalimumab Market Overview, Trends and Forecast 2015

12-26-2017 11:26 AM CET | Health & Medicine

Press release from: TMR

/ PR Agency: TMR
LATAM Adalimumab Market Overview, Trends and Forecast 2015

The Latin America (LATAM) adalimumab market features the dominance of few companies operating amid a lackluster market, a limited set of growth opportunities, and the looming threat of biosimilars, observes Transparency Market Research in a report. The drug being a biologic, carries a high price tag, making it difficult for the largely cost-conscious consumers in the region to procure it. The presence of several biosimilars and the projected introduction of several new varieties in the next few years have intensified cost competition in the market. 

In a bid to retain their command and gain sustainable returns in this scenario, companies in the market have reduced costs of adalimumab. On a positive note, the increasing availability of biosimilars in the region is expected to increase the scope of usage of the drug in the next few years. 

Request to view Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8716

Transparency Market Research estimates that the LATAM adalimumab market will exhibit a meagre CAGR of 0.4% over the period between 2015 and 2023, rising from a valuation of US$994.8 mn in 2014 to US$1,186.4 mn by 2023. 

Brazil to Present Most Promising Growth Opportunities for Adalimumab Market

In terms of application, the segment of rheumatoid arthritis dominated the LATAM adalimumab market in 2014 and is likely to retain its position as the leading revenue contributor to the overall market over the report’s forecast period. From a geographical standpoint, the market for adalimumab in Argentina, Mexico, and Brazil presently have the most promising growth opportunities. Of these, Brazil has emerged as the leading revenue generator, with a valuation of US$276.7 mn in 2014. The market for adalimumab in Brazil is projected to expand at a 1.2% CAGR from 2015 to 2023. 

Other countries in the LATAM region, including Venezuela, Chile, Peru, and Columbia, the majority of population belongs to low or middle income categories. Furthermore, these countries lack proper regulatory frameworks for the sale of biosimilars and have a near nonexistence of domestic production facilities. As a result, the sales of adalimumab in these countries are expected to remain dull over the report’s forecast period. 

Adalimumab Sales in LATAM Countries to Benefit from Favorable Government Policies

The market for adalimumab in Latin America is expected to suffer from impending patent expiries of a number of blockbuster drugs. However, despite the slow growth witnessed by the market in the past few years, sales of adalimumab in the region are expected to gain strength owing to favorable government policies. Moreover, rising investment of native and international companies in R&D practices aimed at the development of biologics will also drive sales of adalimumab in the region over the report’s forecast period. 

High Costs of Clinical Trials and R&D to Deter Growth

Although a number of companies are looking to capitalize on the favorable growth opportunities offered by the Brazil market, the high and rising costs incurred in undertaking clinical trials and R&D activities compel companies to increase costs of their products to gain sustainable returns. This factor inhibits the growth of the adalimumab market in Latin America to a large extent. Moreover, the region also has the absence of favorable reimbursement policies for biologics, adversely impacting the overall growth prospects of the LATAM adalimumab market.

View Report @ https://www.transparencymarketresearch.com/latam-adalimumab-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release LATAM Adalimumab Market Overview, Trends and Forecast 2015 here

News-ID: 875343 • Views: 191

More Releases from TMR

Cognitive Assessment and Training Market Trends and Key Players Analysis Report …
TMR Research report on the Cognitive Assessment and Training market stands out from others due to the experience of the TMR experts. The market survey conducted by the team of analysts includes various aspects that influence the market growth such as competitive analysis, key trends, regional perspective, challenges, and new launches. The stakeholders receive thorough and accurate information on the state of the market thanks to the innovative and analytical
Smart Water Management Market Present Scenario and Growth Prospects 2019 - 2027, …
TMR Research report on the Smart Water Management market stands out from others due to the experience of the TMR experts. The market survey conducted by the team of analysts includes various aspects that influence the market growth such as competitive analysis, key trends, regional perspective, challenges, and new launches. The stakeholders receive thorough and accurate information on the state of the market thanks to the innovative and analytical thought
Backend as a Service (Baas) Market to Receive Overwhelming Hike in Revenues by 2 …
TMR Research report on the Backend as a Service (Baas) market stands out from others due to the experience of the TMR experts. The market survey conducted by the team of analysts includes various aspects that influence the market growth such as competitive analysis, key trends, regional perspective, challenges, and new launches. The stakeholders receive thorough and accurate information on the state of the market thanks to the innovative and
Millimeter Wave Equipment Market Projected to Gain Significant Value through 201 …
TMR Research report on the Millimeter Wave Equipment market stands out from others due to the experience of the TMR experts. The market survey conducted by the team of analysts includes various aspects that influence the market growth such as competitive analysis, key trends, regional perspective, challenges, and new launches. The stakeholders receive thorough and accurate information on the state of the market thanks to the innovative and analytical thought

All 5 Releases


More Releases for LATAM

LATAM Pain Management Drug Market Report 2020-2027
According to a new report published by Report Ocean, titled, “LATAM Pain management drug market by drug class and indication: regional opportunity analysis and industry forecast, 2019–2027. GET SAMPLE PAGES @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1316 The LATAM pain management drugs market was valued at $2,683.82 million in 2019, and is projected to reach $3,383.20 million by 2027, registering a CAGR of 3.5% from 2020 to 2027. Pain is a complex medical condition, which not only
LATAM Hypoactive Sexual Desire Disorder Treatment Market Report 2020-2027
According to a new report published by Report Ocean, titled, "LATAM hypoactive sexual desire disorder treatment market by Treatment Type and Sales Channel: Regional Opportunity Analysis and Industry Forecast, 2019–2027," the LATAM hypoactive sexual desire disorder treatment market size was valued at $967million in 2019, and is expected to reach $1,275 million by 2027, registering a CAGR of 6.1% from 2019 to 2027. GET SAMPLE PAGES @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1315 Hypoactive sexual desire
Pipeline Analysis: LATAM Adalimumab Market
The Latin America (LATAM) adalimumab market features the dominance of few companies operating amid a lackluster market, a limited set of growth opportunities, and the looming threat of biosimilars, observes Transparency Market Research in a report. The drug being a biologic, carries a high price tag, making it difficult for the largely cost-conscious consumers in the region to procure it. The presence of several biosimilars and the projected introduction of
10-11-2017 | Health & Medicine
TMR
LATAM Adalimumab Market – Global Industry Analysis 2015
The Latin America (LATAM) adalimumab market features the dominance of few companies operating amid a lackluster market, a limited set of growth opportunities, and the looming threat of biosimilars, observes Transparency Market Research in a report. The drug being a biologic, carries a high price tag, making it difficult for the largely cost-conscious consumers in the region to procure it. The presence of several biosimilars and the projected introduction of several new
LATAM Cord Blood Banking Services Market: Regional & Competitive Analysis
A per the TMR’s report, the Latin America market for cord blood banking services was worth US$196.9 mn in 2014. Researchers project the market to proliferate at a CAGR of 9.40% over the period from 2015 to 2023 and attain a value of US$445.4 mn by the end of the forecast period. View Full Report: http://www.transparencymarketresearch.com/latam-cord-blood-banking-services-market.html Public Cord Blood Banking Services to Report Dominance Currently, cord blood banking services are being
Mobile Broadband LatAm looks at expected market explosion
The largest Latin American mobile network operators and global high-tech giants are meeting in Rio de Janeiro in April to strategize on how best to take advantage of the enormous explosion that is expected in the entire Latin American mobile broadband market. Mobile Broadband LatAm is the first event to bring together the entire industry ecosystem and takes place from 7-9 June. MTN, the South African mobile operator